Subspecialties Liquid biopsy, Oncology, Screening and monitoring

Secrets in Circulating Tumor Biomarkers

What ctDNA and CTCs can tell us about the likelihood of breast cancer survival and recurrence

Michael Schubert | 08/21/2020 | Quick Read

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Subspecialties Liquid biopsy, Oncology, Screening and monitoring

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

Investigating cell-free DNA in liquid biopsy

06/09/2020 | Contributed by Cytiva

OncoKDM Lite: Improving TSO500 data interpretation accuracy from VCF files in oncology routine practice

03/02/2020 | Contributed by OncoDNA

Delivering precision health: the role of molecular diagnostics

09/04/2019 | Contributed by Cytiva

Subspecialties Oncology

Identifying HER2-low expression – A pathologist led slide review

12/14/2022 | Sponsored by Roche

Subspecialties Oncology

Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer

05/31/2022 | Sponsored by Ultivue

Subspecialties Oncology

Two Perspectives: Patient and Hematopathologist Discussion on Importance of CML Monitoring

05/24/2022 | Sponsored by Cepheid

Subspecialties Histology

Case of the Month

01/04/2023

Subspecialties Histology

Image of the Month

01/19/2023 | Alan A. George

Outside the Lab Point of care testing

Multiplex Testing for Respiratory Viruses

12/13/2022 | Sponsored by Seegene

Diagnostics Genetics and epigenetics

Does Dyslexia Have a Genotype?

01/24/2023 | Georgia Hulme

Diagnostics Genetics and epigenetics

Research Roundup

01/25/2023 | Georgia Hulme